Clinical Trial Update: Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the direct renin inhibitor aliskiren on endothelial function and arterial stiffness in diabetic subjects was terminated; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension
• Prehypertension

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Diabetes, Pre-hypertension | Phase 4 | Status: TERMINATED | Results posted: 2014-06-30